PT Kalbe Valuation
| PTKFF Stock | USD 0.1 0.01 13.55% |
PT Kalbe seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of PT Kalbe Farma from inspecting the company fundamentals such as return on asset of 0.11, and Shares Owned By Institutions of 15.23 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that PT Kalbe's price fluctuation is out of control at this time. Calculation of the real value of PT Kalbe Farma is based on 3 months time horizon. Increasing PT Kalbe's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the PTKFF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of PT Kalbe Farma. Since PT Kalbe is currently traded on the exchange, buyers and sellers on that exchange determine the market value of PTKFF Pink Sheet. However, PT Kalbe's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0951 | Real 0.084 | Hype 0.1 | Naive 0.091 |
The real value of PTKFF Pink Sheet, also known as its intrinsic value, is the underlying worth of PT Kalbe Farma Company, which is reflected in its stock price. It is based on PT Kalbe's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of PT Kalbe's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of PT Kalbe Farma helps investors to forecast how PTKFF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of PT Kalbe more accurately as focusing exclusively on PT Kalbe's fundamentals will not take into account other important factors: PT Kalbe Total Value Analysis
PT Kalbe Farma is at this time forecasted to have takeover price of 6.11 B with market capitalization of 7.34 B, debt of 490.28 B, and cash on hands of 189.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the PT Kalbe fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6.11 B | 7.34 B | 490.28 B | 189.29 M |
PT Kalbe Investor Information
About 58.0% of the company outstanding shares are owned by corporate insiders. The company last dividend was issued on the 31st of May 2022. PT Kalbe Farma had 5:1 split on the 8th of October 2012. Based on the measurements of operating efficiency obtained from PT Kalbe's historical financial statements, PT Kalbe Farma is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.PT Kalbe Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. PT Kalbe has an asset utilization ratio of 102.32 percent. This implies that the Company is making $1.02 for each dollar of assets. An increasing asset utilization means that PT Kalbe Farma is more efficient with each dollar of assets it utilizes for everyday operations.PT Kalbe Ownership Allocation
PT Kalbe Farma secures a total of 46.26 Billion outstanding shares. PT Kalbe shows serious amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company retains, if the real value of the company is less than the current market value, you may not be able to make money on it.PT Kalbe Profitability Analysis
The company reported the revenue of 26.26 T. Net Income was 3.18 T with profit before overhead, payroll, taxes, and interest of 11.11 T.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates PT Kalbe's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in PT Kalbe and how it compares across the competition.
About PT Kalbe Valuation
The pink sheet valuation mechanism determines PT Kalbe's current worth on a weekly basis. Our valuation model uses a comparative analysis of PT Kalbe. We calculate exposure to PT Kalbe's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of PT Kalbe's related companies.PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. PT Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.
8 Steps to conduct PT Kalbe's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates PT Kalbe's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct PT Kalbe's valuation analysis, follow these 8 steps:- Gather financial information: Obtain PT Kalbe's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine PT Kalbe's revenue streams: Identify PT Kalbe's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research PT Kalbe's industry and market trends, including the size of the market, growth rate, and competition.
- Establish PT Kalbe's growth potential: Evaluate PT Kalbe's management, business model, and growth potential.
- Determine PT Kalbe's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate PT Kalbe's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
PT Kalbe Growth Indicators
Investing in growth stocks can be very risky. If the company such as PT Kalbe does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 46.9 B | |
| Quarterly Earnings Growth Y O Y | 0.087 | |
| Forward Price Earnings | 26.3158 | |
| Retained Earnings | 18.7 T |
Complementary Tools for PTKFF Pink Sheet analysis
When running PT Kalbe's price analysis, check to measure PT Kalbe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PT Kalbe is operating at the current time. Most of PT Kalbe's value examination focuses on studying past and present price action to predict the probability of PT Kalbe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PT Kalbe's price. Additionally, you may evaluate how the addition of PT Kalbe to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |